High CV burden ‘magnifies dementia risk’ in adults with focal epilepsy
Cardiovascular disease risk modification may be critical to preventing adults with focal epilepsy from developing dementia in later life, UK doctors report. The advice follows…
Rachel Fieldhouse
Rachel is a reporter with Australian Doctor Group.
Losing weight ‘ups risk of death’ among healthy older patients
Healthy older adults who lose more than 10% of their body weight are more than twice as likely to die from any cause compared with…
PBS abruptly restricts GP prescribing of kids’ asthma inhaler
GPs say they have been blindsided by new PBS rules on initiating the asthma preventer fluticasone propionate in young children without non-GP specialist input. Since…
Bite from cake-snatching iguana leads to rare infection: case
A young girl has become the victim of an unusual crime and the subject of the first reported case of a Mycobacterium marinum infection from…
Limit further COVID-19 boosters to high-risk patients, WHO says
Additional COVID-19 vaccine boosters are not recommended for patients outside of high-priority groups, according to new international guidance. The WHO says booster shots should be…
GP in $574,000 work-from-home case ‘imprudently’ rejected settlement offers: judge
A GP ordered to pay $574,000 for breaching a six-year contract with a corporate “imprudently” refused four offers to settle the case, a federal court judge…
Inflammation predicts CV events ‘better than lipids’ in patients taking statins
Vascular inflammation is a better predictor of future cardiovascular events and death than LDL cholesterol in patients on statin therapy, US doctors report. Their meta-analysis…
Exercise caution when prescribing analgesics for back pain: study
Analgesics may be no better than placebo for managing acute lower back pain in adults, according to Australian and UK researchers who found only low-certainty…
Medicare should fund pharmacy prescribing trials: Productivity Commission
Pharmacists should receive Medicare funding for consultations under state-based pharmacy prescribing trials, the Productivity Commission has recommended. The commission’s Five-Year Productivity Inquiry report, released last…
PBS delisting triggers govt intervention on diabetes drug
The Federal Government says fast-acting insulin products Fiasp and Fiasp FlexTouch will be subsidised for patients with type 1 diabetes for an extra six months…
